Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis and severe sepsis in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure. - Complicated urinary tract infections: eliminates resistant uropathogens and resolves infection. - Nosocomial pneumonia: achieves rapid bacterial clearance in hospital‑acquired lung infections. - Meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections. - Severe sepsis: offers potent activity against multi‑drug‑resistant organisms to control systemic infection.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Headache: transient mild headache.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile colitis: antibiotic‑associated colitis presenting with severe diarrhea.

Careful assessment and monitoring are required when using meropenem.

- Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Seizure risk: monitor neurologic status in patients with pre‑existing CNS disease. - Pregnancy: use only if potential benefits justify potential risks to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, heightening toxicity. - Cimetidine: can raise meropenem levels by inhibiting renal tubular secretion.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor electrolytes for additive renal effects. - Aminoglycosides: increased risk of nephrotoxicity when combined. - Warfarin: may alter INR, requiring closer anticoagulation monitoring.